REGENXBIO Inc.

NASDAQ: RGNX
Share price (12/20/24): $7.62
Market cap (12/20/24): $378 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 79 pages Agreement and Plan of Merger by and Among: Dimension Therapeutics, Inc., a Delaware Corporation; Regenxbio Inc., a Delaware Corporation; and Muddy Charles Acquisition Corporation, a Delaware Corporation Dated as of August 24, 2017

from 425 79 pages Agreement and Plan of Merger by and Among: Dimension Therapeutics, Inc., a Delaware Corporation; Regenxbio Inc., a Delaware Corporation; and Muddy Charles Acquisition Corporation, a Delaware Corporation Dated as of August 24, 2017